Cardiac allograft vasculopathy after heart transplantation: risk factors and management

This publication has 48 references indexed in Scilit:

• Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
  New England Journal of Medicine, 2003
• Tacrolimus excels cyclosporine a in prevention of cardiac allograft vasculopathy - a prospective IVUS, angiography and Doppler study
  The Journal of Heart and Lung Transplantation, 2002
• Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging
  The Journal of Heart and Lung Transplantation, 2000
• A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH.
  The Journal of Heart and Lung Transplantation, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients
  Journal of the American College of Cardiology, 1995
• CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS
  Transplantation, 1995
• Cardiac allograft vasculopathy: Current concepts
  American Heart Journal, 1995
• An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy
  The American Journal of Cardiology, 1995
• Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors
  The American Journal of Cardiology, 1994